Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Circ Cardiovasc Imaging. 2015 Jun;8(6):10.1161/CIRCIMAGING.114.002846 e002846. doi: 10.1161/CIRCIMAGING.114.002846

Table 3.

Echocardiographic Functional Characteristics According to Alcohol Consumption and Sex

Model 1- alcohol
consumption Visit 5
Model 2- alcohol
consumption Visit 5
Model 2- cumulative
average alcohol
consumption

N drinks/week Non-drinker 0 to 7 7 to 14 ≥14 Coef. (SE) P Value Coef. (SE) P Value Coef. (SE) P Value
Total Participants (n, %) 2402 (53.7) 1467 (32.8) 402 (9.0) 195 (4.4)
Men (M) 665 (37.3) 707 (39.7) 261 (14.7) 148 (8.3)
Women (W) 1737 (64.7) 760 (28.3) 141 (5.3) 47 (1.8)
LV ejection fraction (%) M 63.6 ± 7.1 63.6 ± 7.5 63.1 ± 6.3 64.3 ± 6.5 .17 (.55) 0.752 .11 (.59) 0.845 −.13 (.60) 0.818
W 66.5 ± 5.9 66.2 ± 5.7 65.6 ± 6.9 65.5 ± 6.5 −1.2 (.54) 0.020 −1.9 (.62) 0.002 −2.1 (.66) 0.001
Global long. LV strain (%) M −17.3 ± 2.9 −17.5 ± 2.6 −17.4 ± 2.5 −17.4 ± 2.7 −.005(.21) 0.808 .001 (.23) 0.983 .05 (.23) 0.823
W −18.3 ± 2.5 −18.6 ± 2.4 −18.1 ± 2.5 −18.1 ± 2.4 .45 (.22) 0.044 .45 (.25) 0.075 .42 (.27) 0.121
SD Time to peak longitudinal LV strain (msec) M 66.9± 43.6 66.9 ± 39.0 61.1 ± 32.4 63.1 ± 48.4 −4.2 (3.3) 0.206 −2.4 (3.7) 0.521 −5.4 (3.7) 0.145
W 59.9 ± 33.2 57.6 ± 28.5 52.2 ± 26.8 58.7 ± 25.3 −6.0 (2.9) 0.042 −6.4 (3.3) 0.055 −6.2 (3.5) 0.078
E/A ratio M 0.9 ± 0.4 0.9 ± 0.3 0.9 ± 0.3 0.9 ± 0.4 .04 (.02) 0.100 .01 (.02) 0.593 −.001 (.02) 0.895
W 0.8 ± 0.3 0.9 ± 0.3 0.9 ± 0.3 0.9 ± 0.3 .11 (.02) <0.001 .08 (.02) 0.005 .06 (.03) 0.030
E/E’ ratio M 9.4 ± 3.8 9.5 ± 3.8 9.7 ± 4.6 10.1 ± 3.7 1.1 (.30) <0.001 .82 (.33) 0.014 .59 (.33) 0.077
W 10.8 ± 4.1 10.6 ± 4.0 10.3 ± 3.8 11.14 ± 4.0 −.02 (.35) 0.948 −.19 (.41) 0.643 −.24 (.43) 0.577
LV diastolic function classification (n, %) M −.01 (.02) 0.508 −.03 (.09) 0.704 −.02 (.09) 0.816
Unclassified 82 (13.3) 97 (14.8%) 33 (13.7) 20 (14.8) .03 (.02) 0.212 .02 (.03) 0.460 .02 (.03) 0.389
Normal 202 (32.7) 236 (35.9%) 100 (41.5) 53 (39.3) .04 (.03) 0.212 .04 (.04) 0.251 .01 (.04) 0.828
Mild 194 (31.4) 181 (27.5%) 51 (21.2) 23 (17.0) −.14 (.03) <0.001 −.13 (.04) 0.001 −.07 (.04) 0.054
Moderate-severe 140 (22.7) 143 (21.8%) 57 (23.7) 39 (28.9) .65 (.35) 0.063 .06 (.03) 0.114 .04 (.03) 0.270
LV diastolic function classification (n, %) W −.01 (.10) 0.865 −.10 (.12) 0.401 −.11 (.12) 0.387
Unclassified 387 (23.0) 145 (19.8%) 32 (23.9) 12 (26.1) .02 (.03) 0.790 .02 (.04) 0.528 .01 (04) 0.664
Normal 371 (22.0) 213 (29.0%) 40 (29.9) 12 (26.1) .04 (.03) 0.274 .06 (.04) 0.172 .08 (.04) 0.061
Mild 405 (24.0) 139 (18.9%) 22 (16.4) 5 (10.9) −.09 (.03) 0.011 −.10 (.04) 0.019 −.12 (.04) 0.007
Moderate-severe 521 (30.9) 237 (32.3%) 40 (29.9) 17 (37.0) .04 (.04) 0.303 .01 (.04) 0.792 .01 (.05) 0.760
RV fractional area change M 0.50 ± 0.08 0.50 ± 0.08 0.51 ± 0.07 0.51 ± 0.08 .01 (.001) 0.083 .001 (.001) 0.382 −.001 (.001) 0.935
W 0.54 ± 0.08 0.53 ± 0.08 0.53 ± 0.08 0.53 ± 0.07 −.01 (.01) 0.049 −.00(.00) 0.275 −.01 (.001) 0.240
Tricuspid annulus peak systolic velocity (cm/s) M 11.3 ± 2.8 11.5 ± 3.1 11.8 ± 3.1 12.3 ± 3.1 .86 (.23) <0.001 .86 (.23) 0.001 .84 (.26) 0.012
W 11.7 ± 2.9 11.8 ± 2.7 11.5 ± 2.8 11.7 ± 2.9 −.12 (.25) 0.618 −.12 (.25) 0.719 −.10 (.28) 0.969

Model 1: adjusted for age, body mass index, diabetes, previously diagnosed myocardial infarction, anti-hypertensive treatment and systolic blood pressure. Model 2: adjusted for Model 1 + education and income level and cigarette smoking in all visits.Coef. (SE), estimated difference per consumption category (standard error)